Zenas BioPharma (ZBIO) Current Leases (2023 - 2026)
Zenas BioPharma (ZBIO) recorded quarterly Current Leases of $1.0 million in Q1 2026, down 7.0% quarter-over-quarter from $1.1 million in Q4 2025, and up 14.21% on a YoY basis from $908000.0 in Q1 2025.
Zenas BioPharma (ZBIO) Current Leases (2023 - 2026) Analysis & Trends
Zenas BioPharma's Current Leases history runs 4 years deep, the most recent figure standing at $1.0 million for Q1 2026.
- In Q1 2026, Current Leases rose 14.21% year-over-year to $1.0 million; the TTM figure through Mar 2026 stood at $1.0 million (up 14.21% YoY), while the FY2025 annual figure was $1.1 million, up 42.04% from the prior year.
- Current Leases was $1.0 million for Q1 2026 at Zenas BioPharma, down from $1.1 million in the prior quarter.
- In the past five years, Current Leases ranged from a high of $1.1 million in Q4 2025 to a low of $384000.0 in Q3 2024.
- Historically, Current Leases has averaged $774500.0 across 4 years, with a median of $789000.0 in 2024.
- The sharpest annual moves came in 2025 and 2026: Current Leases surged 60.94% in 2025, then rose 14.21% in 2026.
- A 4-year view of Current Leases shows it stood at $556000.0 in 2023, then soared by 41.19% to $785000.0 in 2024, then jumped by 42.04% to $1.1 million in 2025, then fell by 7.0% to $1.0 million in 2026.
- The last three Current Leases figures came in at $1.0 million (Q1 2026), $1.1 million (Q4 2025), and $618000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Zenas BioPharma | 1.10 Bn | 379.43 Mn | - | 1.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.04 Mn |
| Dec 31, 2025 | 1.12 Mn |
| Sep 30, 2025 | 618,000.00 |
| Jun 30, 2025 | 793,000.00 |
| Mar 31, 2025 | 908,000.00 |
| Dec 31, 2024 | 785,000.00 |
| Sep 30, 2024 | 384,000.00 |
| Dec 31, 2023 | 556,000.00 |